All News

The Finnish developers of a virtual guitar are looking for investment to develop the technology and to bring it to public venues.

Inexpensive, fun applications can make a big splash in the consumer robotics market, but investors are waiting for a new 'killer app' before putting their money on the table.

A new journal might be worth watching, if you don't mind tearing down barriers between disciplines.

A spin-out from Oxford University is looking to attract the attention of equity investors and pharmaceutical companies by focusing on the discovery and development of small molecules to treat cancer

Big money is going into Europe's nanotechnology. This one has an interesting partnership between research and industry.

Researchers are taking cues from a century-old spray drying technology to see if it could be developed to make better products for the food and pharmaceutical industries. They are now looking for investors and partnership from industry players.

The inventors of an imaging system to improve diagnosis of coronary heart disease are looking at licensing the technology – or getting venture capital to create a spin-out.

A researcher at the Academic Medical Centre in Amsterdam has developed instruments that could assist surgeons to perform keyhole surgery. The centre is now looking for investors and partnership or licensing agreements for the technology.

Cognitive science is moving rapidly from theory to research to practical applications.

The European Union's plan to transform Europe's drug discovery industry borrows some of its style from the US - but not everything.

The European biotechnology sector is back on track, according to Ernst & Young's 20th annual survey of biotechnology.

Europe needs more "angel" investors to finance its start-ups. A Prague conference highlights why it isn't getting them.

The conclusion that there was nothing wrong with the specifics of the TeGenero trial in which six healthy volunteers ended up in intensive care has repercussions for the wider biotech industry.

Things have changed in intellectual property, the biotech industry's big annual get-together in the US has been hearing from India, Malaysia and others.

Innovation has its phases. So does procurement. The challenge is to synchronise them.